; and (2) critical to the public health during a public health emergency declared by the Secretary under section 319 of the Public Health Service Act ( 42 U.S.C. 247(d) . (b) Content Such report shall— (1) identify factors that limit the manufacturing of active pharmaceutical ingredients, finished drug products, and devices described in subsection (a)